News & Events

David Cummings MD is senior author of statement on diabetes surgery

David Cummings MD is senior author of an international consensus statement proposing that gastrointestinal surgery may be a viable alternative therapy for type 2 diabetes in some patients and pointing the way toward new directions in research. “The Diabetes Surgery Summit Consensus Conference: Recommendations for the Evaluation and Use of Gastrointestinal Surgery to Treat Type 2 Diabetes Mellitus,” the first such statement on the topic, was published online on November 24 in the Annals of Surgery.

Read More

D&O researcher Alan Chait MD receives an NIH R01 grant

Alan Chait, MD, Professor and Head of the Division of Metabolism, Endocrinology and Nutrition, was awarded a five year NIH grant for his proposal entitled “Effect of Nutritional Factors on Macrophage Accumulation in Adipose Tissue.”   Dr. Chait is an investigator at the Diabetes & Obesity Center of Excellence.

Read More

David Cummings MD and David Flum MD receive an NIH R01 grant

David E. Cummings, MD, an Associate Professor in the Division of Metabolism, Endocrinology and Nutrition and investigator at the Diabetes & Obesity Center of Excellence, and David Flum, MD, a Professor in the Department of Surgery,  were awarded a five year, 2.2 million dollar NIH grant for their proposal entitled “Mechanisms of Glycemic Improvement Following GI Surgery.” 

Read More

Graduate student Jenny Kanter awarded The Samuel and Althea Stroum Endowed Graduate Fellowship in Diabetes Research

Jenny Kanter, a graduate student working in the laboratory of Diabetes & Obesity Center of Excellence Associate Director, Karin Bornfeldt PhD, was awarded The Samuel and Althea Stroum Endowed Graduate Fellowship in Diabetes Research. The purpose of this fellowship is to support the training of a promising graduate student in the area of diabetes-related research.

Read More

Diabetes Stem Cell Program Launched by The Diabetes & Obesity Center of Excellence and The Institute for Stem Cell and Regenerative Medicine

The Diabetes & Obesity Center of Excellence (DOCE), in partnership with the Institute for Stem Cell and Regenerative Medicine (ISCRM), is actively moving ahead to create the Diabetes Stem Cell Program (DSCP) at UW Medicine Research at South Lake Union. The DSCP is the interface between the DOCE and ISCRM.

Read More

Michael Schwartz MD awarded an NIH Instrumentation Grant

Diabetes & Obesity Center of Excellence Director and Researcher, Michael Schwartz MD, was awarded a one year NIH Instrumentation Grant under the American Recovery and Reinvestment Act (ARRA) program. This award will provide Dr. Schwartz’s group with state-of-the-art equipment to perform energy balance and metabolic phenotyping of rodent models relevant to nutrition, obesity, diabetes and related disorders.

Read More